Center for Sexuality and Health Disparities and Department of Health Behavior and Biological Sciences, School of Nursing and
Department of Technology and Operations, Stephen M. Ross School of Business, University of Michigan, Ann Arbor, Michigan.
Pediatrics. 2021 Mar;147(3). doi: 10.1542/peds.2020-0728. Epub 2021 Feb 4.
Most transgender individuals assigned female at birth use chest binding (ie, wearing a tight garment to flatten chest tissue for the purpose of gender expression), often beginning in adolescence, to explore their gender identity. Although binding is often critical for mental health, negative physical side effects, ranging from chronic pain to rib fractures, are common. Time to first onset of symptoms is unknown.
A community-engaged, online, cross-sectional survey ("The Binding Health Project") enrolled 1800 assigned female at birth or intersex individuals who had ever used chest binding. Lifetime prevalence of 27 pain, musculoskeletal, neurologic, gastrointestinal, generalized, respiratory, and skin or soft tissue symptoms related to binding was assessed. Nonparametric likelihood estimation methods were used to estimate survival curves.
More than one-half (56%) of participants had begun binding by age 21, and 30% had begun by age 18. In 18 of 27 symptoms, the majority of people who go on to experience the event will do so within the first binding-year, but several skin-related and rare but serious outcomes (eg, rib fracture) took longer to occur. Pain presents rapidly but continues to rise in intensity over time, peaking at >5 years of binding.
Although many symptoms emerge quickly, others can take years to develop. Individuals and their clinicians can use this information to make informed decisions on how to structure binding practices and top surgery timing while meeting goals related to gender expression and mental health. Access to puberty blockers may delay initiation of binding, preventing binding-related symptoms in youth.
大多数出生时被指定为女性的跨性别者会使用束胸带(即穿着紧身衣物来压平胸部组织,以表达性别),通常从青春期开始,以探索自己的性别认同。虽然束胸带通常对心理健康至关重要,但常见的是会产生从慢性疼痛到肋骨骨折等各种负面身体副作用。出现症状的首次发作时间尚不清楚。
一项以社区为基础的、在线的、横断面调查(“束胸带健康项目”)招募了 1800 名出生时被指定为女性或患有间性疾病的人,他们曾使用过束胸带。评估了与束胸带相关的 27 种疼痛、肌肉骨骼、神经、胃肠道、全身、呼吸和皮肤或软组织症状的终生患病率。使用非参数似然估计方法来估计生存曲线。
超过一半(56%)的参与者在 21 岁之前开始束胸,30%的人在 18 岁之前开始束胸。在 27 种症状中的 18 种中,大多数经历这些症状的人会在首次束胸的一年内出现,但也有一些皮肤相关的和罕见但严重的后果(例如,肋骨骨折)需要更长的时间才能出现。疼痛会迅速出现,但随着时间的推移,疼痛强度会持续增加,在束胸 5 年以上时达到峰值。
虽然许多症状很快出现,但其他症状可能需要数年时间才能发展。个人及其临床医生可以使用这些信息来做出明智的决策,以确定如何构建束胸实践和胸部手术时间,同时满足与性别表达和心理健康相关的目标。青春期阻滞剂的使用可能会延迟束胸的开始,从而防止青少年出现束胸相关症状。